Warrant

Aion Therapeutic Announces Closing of Non-Brokered Private Placement

Friday, June 11, 2021 - 10:45pm

Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering").

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - June 11, 2021) - Aion Therapeutic Inc. (CSE: AION) ("Aion Therapeutic" or the "Company") is pleased to announce the closing of a non-brokered private placement through the issuance of 16,994,475 units (each, a "Unit") at a price of $0.0875 per Unit for gross proceeds of $1,487,016.56 (the "Offering").
  • Each Unit is comprised of one common share (each, a "Common Share") of the Company and one-half of one Common Share purchase warrant (each whole warrant, a "Warrant").
  • Each Warrant entitles the holder thereof to acquire one Common Share for a period of twenty-four months from the closing of the Offering (the "Expiry Date") at a price of $0.15 per Common Share.
  • In addition, Aion Therapeutic is creating a strong international intellectual property portfolio related to its discoveries.

Ipsidy Announces Reverse Stock Split Effective Monday June 14, 2021

Friday, June 11, 2021 - 9:05pm

LONG BEACH, N.Y., June 11, 2021 (GLOBE NEWSWIRE) -- Ipsidy Inc. (www.ipsidy.com) [OTCQB:IDTY] a leading provider of Identity as a Service (IDaaS), delivering a suite of secure, mobile, biometric identity verification solutions,today announced that effective June 14, 2021 it will complete a 1-for-30 reverse stock split of its common stock (Reverse Stock Split).

Key Points: 
  • LONG BEACH, N.Y., June 11, 2021 (GLOBE NEWSWIRE) -- Ipsidy Inc. (www.ipsidy.com) [OTCQB:IDTY] a leading provider of Identity as a Service (IDaaS), delivering a suite of secure, mobile, biometric identity verification solutions,today announced that effective June 14, 2021 it will complete a 1-for-30 reverse stock split of its common stock (Reverse Stock Split).
  • As a result, on Monday, June 14, 2021 every 30 issued shares of Common Stock will automatically be combined into one share of Common Stock.
  • The Companys common stock will trade under a new and temporary ticker symbol IDTYD for a period of 20 business days including the effective date of the Reverse Stock Split.
  • Further information about how the reverse stock split affects the individual holdings of investors, whether holders of certificates for Common Stock, or warrants, options, or notes convertible into Common Stock will be provided to investors following the effective date.

Lion Announces Response to SEC Guidance Issued on April 12, 2021 Applicable to Warrants Issued by Special Purpose Acquisition Companies ("SPACs")

Friday, June 11, 2021 - 9:30pm

Consistent with market practice among SPACs, the Company had been accounting for the Public and Private Warrants as equity.

Key Points: 
  • Consistent with market practice among SPACs, the Company had been accounting for the Public and Private Warrants as equity.
  • The Company does not anticipate the restatement to impact its previously communicated non-GAAP operating metrics for 2020.
  • Finally, as of today, the Company has approximately 11.5 million Public Warrants and 5.4 million Private Warrants outstanding.
  • Lion cautions readers not to place undue reliance upon any forward-looking statements, which speak only as of the date made.

Novo Announces Supplemental Listing of Additional Warrants

Friday, June 11, 2021 - 2:03pm

VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (TSX: NVO & NVO.WT) is pleased to announce that the Toronto Stock Exchange (the TSX) has accepted for listing 5,176,500 common share purchase warrants of the Company (the 2021 Warrants).

Key Points: 
  • VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- Novo Resources Corp. (Novo or the Company) (TSX: NVO & NVO.WT) is pleased to announce that the Toronto Stock Exchange (the TSX) has accepted for listing 5,176,500 common share purchase warrants of the Company (the 2021 Warrants).
  • Each 2021 Warrant is exercisable for one common share of the Company at an exercise price of C$3.00 until May 4, 2024.
  • The Company currently has 8,596,184 common share purchase warrants (the 2020 Warrants) listed for trading on the TSX under the symbol NVO.WT (CUSIP: 67010B136).
  • The 2020 Warrants were first listed for trading on the TSX Venture Exchange on November 10, 2020.

Hemostemix Announces the Closing of a $2,500,000 Convertible Debenture

Friday, June 11, 2021 - 1:10pm

In the action pending in Delaware Federal Court, on June 1st Hemostemix, the plaintiff, moved to dismiss Aspire's counterclaims.

Key Points: 
  • In the action pending in Delaware Federal Court, on June 1st Hemostemix, the plaintiff, moved to dismiss Aspire's counterclaims.
  • The debenture offering (the "Debenture Offering") is a $2,500,000 five-year unsecured non-transferrable convertible debenture, with conversion at the option of Hemostemix, and consists of 2,500 debenture units (each, a "Debenture Unit") at a price of $1,000 per Debenture Unit.
  • Each Debenture Unit consists of a $1,000 principal amount debenture (each, a "Debenture") and 2,500 Debenture Warrants.
  • This forward-looking information reflects Hemostemix's current beliefs and is based on information currently available to Hemostemix and on assumptions Hemostemix believes are reasonable.

AREV CEO Michael Withrow Buys 900,000 Shares of Company Stock

Friday, June 11, 2021 - 12:15pm

VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV or the Company) is pleased to announce that its Chief Executive Officer, Michael Withrow, has purchased a total of 900,000 shares, including private placement purchases and the exercising of warrants.

Key Points: 
  • VANCOUVER, British Columbia, June 11, 2021 (GLOBE NEWSWIRE) -- AREV NANOTEC BRANDS INC. (CSE: AREV) (OTC: AREVF) (AREV or the Company) is pleased to announce that its Chief Executive Officer, Michael Withrow, has purchased a total of 900,000 shares, including private placement purchases and the exercising of warrants.
  • Mr. Withrow commented: "When I study our core competencies and vision, along with the people working with the Company, I see a huge opportunity in the multiple markets that we operate in.
  • These relationships enable the Company to design and develop innovative products in a shorter time frame than current industry standards.
  • The company has issued 100,000 stock options to Directors, Officers and Consultants of the Company at a price of $0.185 for a period of 5 years from the issued date.

Quantum-Si, Revolutionizing Proteomics, Closes Business Combination and Will Begin Trading Under the Ticker “QSI” on the Nasdaq Stock Exchange

Thursday, June 10, 2021 - 5:04pm

Following the transaction, the combined company was renamed Quantum-Si Incorporated, and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (Nasdaq) on June 11, 2021 under the symbols QSI and QSIAW, respectively.

Key Points: 
  • Following the transaction, the combined company was renamed Quantum-Si Incorporated, and its Class A common stock and warrants will begin trading on the Nasdaq Global Market (Nasdaq) on June 11, 2021 under the symbols QSI and QSIAW, respectively.
  • The final Exchange Ratio for which the former Quantum-Si stockholders exchanged their shares of Quantum-Si capital stock for common stock of the combined company was 0.7975.
  • Each share of HighCape Class A common stock and HighCape Class B common stock became one share of the combined companys Class A common stock.
  • Quantum-Si has created the first next-generation single-molecule proteomics and genomics platform with the goal of revolutionizing the growing field of proteomics.

Advantagewon Oil Corp. Closes Over $1,000,000 Initial Tranche of Financing

Thursday, June 10, 2021 - 2:15pm

The Corporation intends to use the net proceeds of the Offering for working capital and general corporate purposes.

Key Points: 
  • The Corporation intends to use the net proceeds of the Offering for working capital and general corporate purposes.
  • Each Unit is comprised of one common share in the capital of the Corporation (a "Common Share") and one Common Share purchase warrant (a "Warrant").
  • AOC intends to close a second tranche of the Offering on or before June 25, 2021.
  • $50,000 of the combined debt total was settled via the issuance of 100,000 Common Shares at a price of $0.50 CDN per Common Share.

Zealand Pharma increases its share capital as a consequence of exercise of employee warrants

Thursday, June 10, 2021 - 2:00pm

17.263 warrants er udnyttet den 15. april 2020, 38.121 warrants er udnyttet den 26. maj 2020, 14.495 warrants er udnyttet den 12. juni 2020, 8.050 er udnyttet den 21. august 2020, 2.976 warrants er udnyttet den 11. september 2020, 11.495 warrants er udnyttet den 20. november 2020, 3.250 warrants er udnyttet den 11. december 2020, 3.770 warrants er udnyttet den 19. marts 2021, 3.900 warrants er udnyttet den 9. april 2021, 2.000 warrants er udnyttet den 20. maj 2021, og 4.395 warrants er udnyttet den 10. juni 2021.

Key Points: 
  • 17.263 warrants er udnyttet den 15. april 2020, 38.121 warrants er udnyttet den 26. maj 2020, 14.495 warrants er udnyttet den 12. juni 2020, 8.050 er udnyttet den 21. august 2020, 2.976 warrants er udnyttet den 11. september 2020, 11.495 warrants er udnyttet den 20. november 2020, 3.250 warrants er udnyttet den 11. december 2020, 3.770 warrants er udnyttet den 19. marts 2021, 3.900 warrants er udnyttet den 9. april 2021, 2.000 warrants er udnyttet den 20. maj 2021, og 4.395 warrants er udnyttet den 10. juni 2021.
  • Som flge af dels udnyttelse, dels bortfald af warrants, er det udestende antal warrants, der kan udnyttes, reduceret til 182.535 warrants.
  • As a result of exercise/lapse of warrants, the number of warrants available for exercise has been reduced to 182,535 warrants.
  • As a result of exercise/lapse of warrants, the number of warrants available for exercise has been reduced to 324,399 warrants.

Eric Sprott Announces Holdings in Kootenay Silver Inc.

Thursday, June 10, 2021 - 12:09am

Mr. Sprott now owns and controls 30,150,000 common shares and 16,875,000 common share purchase warrants representing approximately 9.4% of the outstanding common shares on a non-diluted basis and approximately 13.9% of the outstanding common shares on a partially-diluted basis.

Key Points: 
  • Mr. Sprott now owns and controls 30,150,000 common shares and 16,875,000 common share purchase warrants representing approximately 9.4% of the outstanding common shares on a non-diluted basis and approximately 13.9% of the outstanding common shares on a partially-diluted basis.
  • Prior to the disposition, Mr. Sprott beneficially owned and controlled 31,150,000 common shares and 16,875,000 common share purchase warrants (representing approximately, 9.7% on a non-diluted basis and approximately 14.2% on a partially diluted basis.
  • The disposition, combined with previous new share issuances by Kootenay Silver, resulted in an ownership change, on a partially diluted basis, of approximately 2.2% since the last filing of an Early Warning Report.
  • Kootenay Silver is located at 1650-1075 West Georgia Street, Vancouver, British Columbia, V6E 3C9.